CClinicalTrials.gg
RecruitingNCT07239232Updated Dec 12, 2025

"Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea

An observational study in Primary Dysmenorrhea, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-12.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Nov 2025; still recruiting 10 months later.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
62
Ages
18 Years to 25 Years
Sex
Female
01

Study summary

The purpose of the study is to assess knee joint position sense, pain and dynamic balance in female with primary dysmenorrhea.

Read the detailed description

Dysmenorrhea is a common condition that typically occurs on its own rather than as a result of pelvic disease. It affects between 50% and 90% of adolescent girls and women of reproductive age and is a major reason for missed days from school or work.

Among the various menstrual disturbances observed, dysmenorrhea was notably prevalent among adolescents and significantly impacted their daily activities. Early diagnosis and awareness of menstrual issues are crucial, as they not only emphasize the need for health education initiatives but also assist in selecting suitable treatments, thereby reducing the adverse effects of these disturbances on adolescents' lives.

However, there is a significant gap in the literature about the effect of Primary dysmenorrhea on knee joint position sense, pain and dynamic balance in young adult female So this study aims to investigate this effect and provide evidence based information in the field of physical therapy.

02

Conditions studied

  • Primary Dysmenorrhea

Keywords

  • Knee
  • Position sense
  • Balance
  • Primary Dysmenorrhea
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Sixty-two healthy female university students will participate in this study. They will be selected randomly from faculty of physical therapy, Cairo University.

Inclusion criteria

  • They should be virgin, healthy female students
  • They have regular menstruation (3-8 days in duration, with 21-35 days in-between).
  • They should have the same activity level mild active female.
  • Their ages will range from 18 to 25 years old.
  • Their body mass index (BMI) will range from 18 to 24.9 Kg/m2.

Exclusion criteria

Exclusion Criteria:

  • History of knee injury, surgery in the knee or spinal vertebrae.
  • Females having any vestibular problems, otitis media, labyrinthitis or any inner ear problems that affect balance
  • Women with any cognitive deficits
  • History of neuromuscular or spinal disease.
  • History of pelvic pathology or any gynecological disease.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
62 participants (estimated)
Patient registry
No

Groups and cohorts

  • Asymptomatic Group

    They have no or mild primary dysmenorrhea.

    Other: No intervention

  • Symptomatic Group

    They have moderate and sever primary dysmenorrhea.

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Overall Stability Index (OSI) . Antero-posterior stability index score (APSI) . Medio lateral stability index score (MLSI) . Over all stability index score (OASI)

    The Overall Stability Index (OSI) is the primary measure of dynamic postural control obtained from the balance assessment system. It reflects the standard deviation of the participant's sway from the platform's center across both the medial-lateral and anterior-posterior directions. Higher OSI values indicate greater instability and poorer balance performance. As an integrated measure of sway variability, the OSI is considered the most comprehensive indicator of overall balance ability and is commonly used to evaluate changes in postural control in response to therapeutic interventions.

    Time frame: at first and fourth menstrual days

  2. Medial-Lateral Stability Index (MLSI)

    The Medial-Lateral Stability Index (MLSI) quantifies the degree of side-to-side sway during balance testing. It represents the standard deviation of medial-lateral movement from the platform's center point, providing a directional measure of postural stability. Elevated MLSI scores reflect increased lateral instability, which may be associated with impaired neuromuscular control or deficits in weight-shifting ability. This variable is useful for identifying balance impairments that predominantly affect frontal plane stability.

    Time frame: at first and fourth menstrual days

  3. Anterior-Posterior Stability Index (APSI)

    The Anterior-Posterior Stability Index (APSI) measures front-to-back sway during dynamic balance assessment. Calculated as the standard deviation of anterior-posterior deviations from the center of the platform, the APSI provides insight into sagittal plane stability. Higher APSI values indicate greater instability and reduced capacity to control forward and backward movements. This index is important for evaluating postural control related to gait, stepping, and activities requiring controlled anterior or posterior shifts in the center of gravity.

    Time frame: at first and fourth menstrual days

  4. knee joint position sense

    using active knee position sense test by universal goniometer.

    Time frame: at first and fourth menstrual days

Secondary outcomes

  1. knee joint pain

    It will be assessed using the Visual analog scale (VAS) for all females in both groups. They will score their level of pain from 1-10, with higher scores indicating more severe pain. It is valid and reliable in pain assessment

    Time frame: at first and fourth menstrual days

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07239232
Lead sponsor
Cairo University
Responsible party
Eman Belal Ahmed (Principal Investigator, Cairo University) — Principal investigator
First posted
Nov 20, 2025
Start date
Nov 18, 2025
Primary completion
Jan 20, 2026 (estimated)
Completion
Jan 30, 2026 (estimated)
Last update
Dec 12, 2025

Study contacts

Eman B ABDUL HAMID, B.Sc
Contact
emanahmed2033e@gmail.com
01158876852
ELHAM s HASSAN, PhD
Contact
elhamramdan70@cu.edu.eg
01206146539
AFAF M BOTLA, PhD
study chair · Assistant Professor, Cairo University
ELHAM s HASSAN, PhD
study director · Lecturer, Cairo university

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion